Rapport Therapeutics Inc.... (RAPP)
undefined
undefined%
At close: undefined
15.10
-19.85%
Pre-market Dec 16, 2024, 04:06 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22
Revenue - -
Cost of Revenue 112.00K 15.00K
Gross Profit -112.00K -15.00K
Operating Income -36.18M -10.37M
Interest Income 2.53M -
Pretax Income -34.78M -10.65M
Net Income -34.79M -10.65M
Selling & General & Admin 8.07M 1.24M
Research & Development 28.00M 9.12M
Other Expenses - -
Operating Expenses 36.07M 10.35M
Interest Expense - 285.00K
Selling & Marketing Expenses -112.00K -
Cost & Expenses 36.18M 10.37M
Income Tax 10.00K -
Shares Outstanding (Basic) 164.35M 36.58M
Shares Outstanding (Diluted) 164.35M 36.58M
EPS (Basic) -0.21 -0.29
EPS (Diluted) -0.21 -0.29
EBITDA -34.66M -10.35M
Depreciation & Amortization 112.00K 15.00K